192 related articles for article (PubMed ID: 1611652)
1. Cefprozil versus cefaclor in the treatment of acute and uncomplicated urinary tract infections. Cefprozil Multicenter Study Group.
Iravani A; Doyle CA; Durham SJ; Wilber RB
Clin Ther; 1992; 14(2):314-26. PubMed ID: 1611652
[TBL] [Abstract][Full Text] [Related]
2. Comparative efficacy and safety of cefprozil and cefaclor in the treatment of acute uncomplicated urinary tract infections.
Christenson JC; Gooch WM; Herrod JN; Swenson E
J Antimicrob Chemother; 1991 Oct; 28(4):581-6. PubMed ID: 1761453
[TBL] [Abstract][Full Text] [Related]
3. Cefprozil versus cefaclor in the treatment of mild to moderate skin and skin-structure infections. The Cefprozil Multicenter Study Group.
Parish LC; Doyle CA; Durham SJ; Wilber RB
Clin Ther; 1992; 14(3):458-69. PubMed ID: 1638587
[TBL] [Abstract][Full Text] [Related]
4. Cefprozil. A review of its antibacterial activity, pharmacokinetic properties, and therapeutic potential.
Wiseman LR; Benfield P
Drugs; 1993 Feb; 45(2):295-317. PubMed ID: 7681376
[TBL] [Abstract][Full Text] [Related]
5. Comparative efficacy and safety of cefprozil versus penicillin, cefaclor and erythromycin in the treatment of streptococcal pharyngitis and tonsillitis.
McCarty JM
Eur J Clin Microbiol Infect Dis; 1994 Oct; 13(10):846-50. PubMed ID: 7889958
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of cefprozil versus other beta-lactam antibiotics in the treatment of lower respiratory tract infections.
Ball P
Eur J Clin Microbiol Infect Dis; 1994 Oct; 13(10):851-6. PubMed ID: 7889959
[TBL] [Abstract][Full Text] [Related]
7. Comparison of cefprozil and cefaclor for treatment of acute urinary tract infections in women.
Iravani A
Antimicrob Agents Chemother; 1991 Sep; 35(9):1940-2. PubMed ID: 1952874
[TBL] [Abstract][Full Text] [Related]
8. Treatment of pharyngitis and tonsillitis with cefprozil: review of three multicenter trials.
McCarty JM; Renteria A
Clin Infect Dis; 1992 Jun; 14 Suppl 2():S224-30; discussion S231-2. PubMed ID: 1617042
[TBL] [Abstract][Full Text] [Related]
9. Review of the experience with cefprozil for the treatment of lower respiratory tract infections.
Pelletier LL
Clin Infect Dis; 1992 Jun; 14 Suppl 2():S238-43; discussion S244-5. PubMed ID: 1617044
[TBL] [Abstract][Full Text] [Related]
10. Comparative efficacy and safety of cefprozil (BMY-28100) and cefaclor in the treatment of acute group A beta-hemolytic streptococcal pharyngitis.
Christenson JC; Swenson E; Gooch WM; Herrod JN
Antimicrob Agents Chemother; 1991 Jun; 35(6):1127-30. PubMed ID: 1929253
[TBL] [Abstract][Full Text] [Related]
11. Loracarbef versus cefaclor in the treatment of cystitis and asymptomatic bacteriuria.
Iravani A
Clin Ther; 1992; 14(1):54-63. PubMed ID: 1576626
[TBL] [Abstract][Full Text] [Related]
12. Cefdinir versus cefaclor in the treatment of uncomplicated urinary tract infection.
Leigh AP; Nemeth MA; Keyserling CH; Hotary LH; Tack KJ
Clin Ther; 2000 Jul; 22(7):818-25. PubMed ID: 10945508
[TBL] [Abstract][Full Text] [Related]
13. Loracarbef (LY163892) versus cefaclor in the treatment of bacterial skin and skin-structure infections in an adult population.
McCarty J; Ruoff GE; Jacobson KD
Am J Med; 1992 Jun; 92(6A):80S-85S. PubMed ID: 1621751
[TBL] [Abstract][Full Text] [Related]
14. Review of in vitro activity, pharmacokinetic characteristics, safety, and clinical efficacy of cefprozil, a new oral cephalosporin.
Barriere SL
Ann Pharmacother; 1993 Sep; 27(9):1082-9. PubMed ID: 8219444
[TBL] [Abstract][Full Text] [Related]
15. Loracarbef versus cefaclor in the treatment of urinary tract infections in women.
Iravani A
Antimicrob Agents Chemother; 1991 Apr; 35(4):750-2. PubMed ID: 2069382
[TBL] [Abstract][Full Text] [Related]
16. Cefaclor into the millennium.
Brumfitt W; Hamilton-Miller JM
J Chemother; 1999 Jun; 11(3):163-78. PubMed ID: 10435677
[TBL] [Abstract][Full Text] [Related]
17. Loracarbef (LY163892) versus cefaclor in the treatment of acute bacterial bronchitis.
Dere WH; Farlow D; Therasse DG; Ruoff GE
Clin Ther; 1992; 14(1):41-53. PubMed ID: 1576625
[TBL] [Abstract][Full Text] [Related]
18. Cefprozil, a new cephalosporin: its use in various clinical trials.
Gainer RB
South Med J; 1995 Mar; 88(3):338-46. PubMed ID: 7886533
[TBL] [Abstract][Full Text] [Related]
19. [A double-blind comparative study of S 6472 (a long-acting cefaclor) versus a conventional cefaclor preparation in complicated urinary tract infections].
Arakawa S; Takagi S; Matsumoto O; Kamidono S; Hirooka K; Hamami G; Matsumoto H; Saito H; Umezu K; Ishigami J
Jpn J Antibiot; 1990 Nov; 43(11):1873-92. PubMed ID: 2287055
[TBL] [Abstract][Full Text] [Related]
20. Multinational multicenter controlled trial comparing ceftibuten with cefaclor for the treatment of acute otitis media. Members of the Ceftibuten Otitis Media International Study Group.
Blumer JL; Mclinn SE; Deabate CA; Kafetzis DA; Perrotta RJ; Salgado O
Pediatr Infect Dis J; 1995 Jul; 14(7 Suppl):S115-20. PubMed ID: 7567311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
